Matthew A. Alti, RPAC

Matthew Alti practices at Vassar Brothers Medical Center (Legacy Hospital - Building B) in Poughkeepsie, New York.

Matthew Alti's NPI, 1285911685, was assigned on November 14, 2011. Matthew Alti holds New York license 015288.

Matthew Alti's primary practice is Vassar Brothers Medical Center (Legacy Hospital - Building B), at 45 Reade Pl, Poughkeepsie, NY 12601 in Dutchess County. The practice phone is (845) 454-8500.

Matthew Alti's primary practice is Vassar Brothers Medical Center (Legacy Hospital - Building B) in Poughkeepsie, New York. Matthew Alti is also affiliated with Vassar Brothers Medical Center. The medical group on file is Pulse-MD Urgent Care. Dmand AI also links Matthew Alti to 1 more hospital and 4 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Matthew Alti practices, 2 sites in all. Vendor and product names are available with a free account.

Medical is Matthew Alti's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. Matthew Alti is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Matthew Alti is licensed in New York.

Dmand AI lists acute sinusitis, acute skin infection, chronic obstructive pulmonary disease (COPD), conjunctivitis, ear eustachian tube disorders, head wound, itchy rashes and joint pain among the conditions Matthew Alti treats.

CMS data shows 39 Medicare services from Matthew Alti across 2 procedure codes in 2024, all of them office visits, for 61 Medicare patients. Medicare paid $1,625 for them. Every service was in an office.

CMS counts 61 Medicare patients who saw Matthew Alti in 2024. The largest group is 65 to 74, with 31 patients. 75% of them have high cholesterol, and 74% have high blood pressure. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Matthew Alti's median patient age at 71, with 35% women.

In 2024, Matthew Alti wrote 233 Medicare Part D claims for 86 patients. 92% of them were for generic drugs. CMS names the drug for 163 of them, across 9 drugs with 11 or more claims each, at $787 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Matthew Alti for performance year 2024, reported as part of a group. Matthew Alti accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 4 general payments to Matthew Alti from 3 drug and device companies in 2025. Education make up the largest share, 52% of the total. Medical Device Business Services, Inc. paid the most, $137.